Literature DB >> 15554428

Hepatitis C virus-associated extrahepatic manifestations: a review.

Damien Sène1, Nicolas Limal, Patrice Cacoub.   

Abstract

The hepatitis C virus (HCV) infection is a worldwide disease that is characterized by a preferential chronic evolution with mild to severe liver disease, including cirrhosis and, in lesser proportion, hepatocarcinoma. Out of these complications, HCV is frequently reported to complicate extrahepatic manifestations. Among those associated to HCV infection with a high degree of certainty, mixed cryoglobulinemia and its complications (skin, neurological, renal, rheumatological involvement) are the most prevalent (50%) in HCV-infected patients. The other diseases include noncryoglobulinemic systemic vasculitis, splenic lymphoma with villous lymphocytes, fatigue, porphyria cutanea tarda, sicca syndrome, and autoantibodies production. The extrahepatic manifestations that share mild-degree certainty of association with HCV infection include B-cell non-Hodgkin lymphoma, autoimmune thrombocytopenia, pruritus, and type II diabetes mellitus. The other diseases such as autoimmune thyroiditis, lichen planus are more questionable for their eventual association with HCV and others (pulmonary fibrosis with or without polymyositis, progressive encephalomyelitis, Mooren's corneal ulcers, erythema nodosum, chronic polyradiculonevritis) are mostly case reports. Howerver, even in cases of tight association, the mechanisms through which HCV may promote or induce extrahepatic manifestations remain unclear and merit further investigations.

Entities:  

Mesh:

Year:  2004        PMID: 15554428     DOI: 10.1023/b:mebr.0000043982.17294.9b

Source DB:  PubMed          Journal:  Metab Brain Dis        ISSN: 0885-7490            Impact factor:   3.584


  214 in total

1.  Cryoglobulinaemia and hepatitis C virus.

Authors:  M Casato; G Taliani; L P Pucillo; F Goffredo; B Laganà; L Bonomo
Journal:  Lancet       Date:  1991-04-27       Impact factor: 79.321

2.  Cryoglobulinemia in Japanese patients with chronic hepatitis C virus infection: host genetic and virological study.

Authors:  A Nagasaka; T Takahashi; T Sasaki; K Takimoto; K Miyashita; M Nakamura; O Wakahama; S Nishikawa; A Higuchi
Journal:  J Med Virol       Date:  2001-09       Impact factor: 2.327

3.  Porphyria cutanea tarda: multiplicity of risk factors including HFE mutations, hepatitis C, and inherited uroporphyrinogen decarboxylase deficiency.

Authors:  Norman G Egger; Douglas E Goeger; Deborah A Payne; Emil P Miskovsky; Steven A Weinman; Karl E Anderson
Journal:  Dig Dis Sci       Date:  2002-02       Impact factor: 3.199

4.  Hepatitis C virus (HCV) in lymphocyte subsets and in B lymphocytes expressing rheumatoid factor cross-reacting idiotype in type II mixed cryoglobulinaemia.

Authors:  A Fornasieri; P Bernasconi; M L Ribero; R A Sinico; M Fasola; J Zhou; G Portera; A Tagger; A Gibelli; G D'amico
Journal:  Clin Exp Immunol       Date:  2000-12       Impact factor: 4.330

Review 5.  Type II mixed cryoglobulinaemia, hepatitis C virus infection, and glomerulonephritis.

Authors:  A Fornasieri; G D'Amico
Journal:  Nephrol Dial Transplant       Date:  1996       Impact factor: 5.992

6.  Porphyria cutanea tarda and antibodies to hepatitis C virus.

Authors:  J P Lacour; I Bodokh; J Castanet; S Bekri; J P Ortonne
Journal:  Br J Dermatol       Date:  1993-02       Impact factor: 9.302

7.  Is hepatitis C virus infection a trigger of porphyria cutanea tarda?

Authors:  C Herrero; A Vicente; M Bruguera; M G Ercilla; J M Barrera; J Vidal; J Terés; J M Mascaró; J Rodés
Journal:  Lancet       Date:  1993-03-27       Impact factor: 79.321

8.  Interferon and ribavirin treatment in patients with hepatitis C-associated renal disease and renal insufficiency.

Authors:  Annette Bruchfeld; Karin Lindahl; Lars Ståhle; Magnus Söderberg; Robert Schvarcz
Journal:  Nephrol Dial Transplant       Date:  2003-08       Impact factor: 5.992

9.  Lower expression of CD81 B-cell receptor in lymphoproliferative diseases associated with hepatitis C virus infection.

Authors:  P Cacoub; M Bourlière; P Hausfater; F Charlotte; H Khiri; S Toci; J C Piette; T Poynard; P Halfon
Journal:  J Viral Hepat       Date:  2003-01       Impact factor: 3.728

10.  Hepatocellular carcinoma in porphyria cutanea tarda: frequency and factors related to its occurrence.

Authors:  P D Siersema; F J ten Kate; P G Mulder; J H Wilson
Journal:  Liver       Date:  1992-04
View more
  29 in total

1.  Local treatment of non healing leg ulcers in a patient with hepatitis C virus infection.

Authors:  Maria G Onesti; Paolo Fioramonti; Diego Massera; Vittoria Amorosi; Pasquale Fino
Journal:  Int Wound J       Date:  2013-06-11       Impact factor: 3.315

2.  Extra-hepatic infection of hepatitis C virus in the colon tissue and its relationship with hepatitis C virus pathogenesis.

Authors:  Helal F Hetta; Mohamed A Mekky; Nasr K Khalil; Wegdan A Mohamed; Mohamed A El-Feky; Shabaan H Ahmed; Enas A Daef; Ahmed Medhat; Mahmoud I Nassar; Kenneth E Sherman; Mohamed Tarek M Shata
Journal:  J Med Microbiol       Date:  2016-05-10       Impact factor: 2.472

3.  Case of chronic eosinophilic leukemia with deletion of chromosome 16 and hepatitis C.

Authors:  Padma Kamineni; Ayanna Baptiste; Mukhtar Hassan; Fitzroy W Dawkins; Syed Zaidi; Ayalew Tefferi; Mercedes Lindsey; Lekidelu Taddesse-Heath
Journal:  J Natl Med Assoc       Date:  2006-08       Impact factor: 1.798

Review 4.  Post-transplant diabetes mellitus: risk reduction strategies in the elderly.

Authors:  Alain Duclos; Lawrence M Flechner; Charles Faiman; Stuart M Flechner
Journal:  Drugs Aging       Date:  2006       Impact factor: 3.923

Review 5.  Evidence for association between hepatitis C virus and Parkinson's disease.

Authors:  Abdelrahman Ibrahim Abushouk; Mostafa Wanees Ahmed El-Husseny; Mayar Magdy; Ammar Ismail; Attia Attia; Hussien Ahmed; Ravikishore Pallanti; Ahmed Negida
Journal:  Neurol Sci       Date:  2017-08-05       Impact factor: 3.307

6.  Hepatitis C treatment of patients with bipolar disorder: a case series.

Authors:  Muhamad Aly Rifai
Journal:  Prim Care Companion J Clin Psychiatry       Date:  2006

Review 7.  [Liver and rheumatism].

Authors:  C Wiegard; A W Lohse
Journal:  Z Rheumatol       Date:  2005-02       Impact factor: 1.372

8.  History of blood transfusion before 1990 is associated with increased risk for cancer mortality independently of liver disease: a prospective long-term follow-up study.

Authors:  Yusuke Inoue; Yasuhiko Wada; Yutaka Motohashi; Akio Koizumi
Journal:  Environ Health Prev Med       Date:  2009-12-17       Impact factor: 3.674

Review 9.  Oculo-renal disorders in infectious diseases.

Authors:  Hassane Izzedine; Irina Buhaescu; Bahram Bodaghi; Valerie Martinez; Eric Caumes; Phuc Lehoang; Gilbert Deray
Journal:  Int Ophthalmol       Date:  2006-03-07       Impact factor: 2.031

Review 10.  Dysmetabolic changes associated with HCV: a distinct syndrome?

Authors:  Amedeo Lonardo; Paola Loria; Nicola Carulli
Journal:  Intern Emerg Med       Date:  2008-02-15       Impact factor: 3.397

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.